Our data demonstrate that embelin can inhibit/reverse pancreatic tumor metastasis by inducing the expression of E-cadherin and inhibiting its associated transcription factors (Snail, Slug, and ZEB1) and MMPs (MMP-2 and MMP-9). This evidence concerns the gene ZEB1 and pancreatic neoplasm.